Studies on cholinesterase inhibitors have demonstrated that, beyond their established efficacy in Alzheimer’s disease, these agents may also exert potential effects on mood disorders related to depression and stress. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.